Abraham Scaria
Company: Beacon Therapeutics
Job title: CSO
Seminars:
Panel Discussion: Novel Modalities & Next Generation of Complement Inhibitors 4:00 pm
Where is the next step for complement inhibitors? Examine the past, present, and future, of complement inhibitors for autoimmune conditions and they may fit alongside existing therapiesRead more
day: End of Conference Day Two
Upstream vs. Downstream Targeting in GA & AMD 1:30 pm
Discussing the advantages and disadvantages of different complement targets through an ophthalmology lens Delivering complement inhibitors to the eye: topical, intravitreal, or systemic? Future considerations for combination therapies to target multiple complement components in the eyeRead more
day: Conference Day Two
Panel Discussion: Dysregulation Insights: An Overview of the Complement System in Health & Human Disease 8:30 am
Unravelling the 3 complement pathways and potential intervention points Understanding core processes in healthy inflammatory response in comparison to pathophysiology of autoimmune conditions Discussing the optimal modalities for delivering complement mediated drugs: small molecules, antibodies, and gene therapiesRead more
day: Conference Day One
Preclinical Updates for Complement Regulators Using Gene Therapies 4:00 pm
The benefits of using gene therapies to target complement mediated diseases Using a localised approach to target the eye and mitigate toxicity Updates in targeting Geographic Atrophy/Dry AMDRead more
day: Conference Day One